All posts by Business Review Webinars

Interview with Christopher Hartnett, Business Development Manager Ireland at EMBALL’ISO








What do you hope attendees will gain at your webinar?

A better understanding of the cold chain process and how EI work to support that process


What discussions do you look forward to having with the attendees?

What their challenges are and advising on best solutions to meet these challenges


What do you enjoy most about your role?

Being involved in an industry that supports the health and wellbeing of people and getting an insight into the developments in the pharma industry


How did you get into the industry?

After a career in the Med Device industry I was given the opportunity(by Stephanie) to join the cold chain solutions world


Where is your favourite place in the world and why?

Africa – time just seems to stand still in Africa


Register now for Brexit, Covid and The Environment by Emball’ISO

Spotlight Interview with Dionis Teshler, CTO & Co-Founder at Guardknox








1. Why did you decide to do a webinar with us? 

We are looking to connect with a professional automotive E/E target audience to in order to discuss the SOA as a concept in modern automotive software design. We aim to raise awareness for the benefits, discuss the challenges and propose solutions which will enable the industry to achieve the vision of the software defined car.

2. What will the audience gain from attending your webinar? 

The audience will gain an understanding of what is SOA and how it was implemented in other industries. The unique challenges for implementation in automotive will be discussed and solutions will be purposed in order to move forward efficiently.

3. How did you get into the industry and what do you most enjoy about your role? 

We decided to move into automotive after a long career in aviation. The most interesting thing about working in automotive is that the products are used by almost everyone every day, which makes it unique and provides a sense of significance to what we are doing. 

4. What are you hoping to achieve in the future in your personal and professional life? 

Bring secure innovative technology to the automotive industry to give consumers what they want and completely transform the driving (or riding) experience, while making a lasting impact on how the automotive industry engages with emerging technology companies. On a personal note, I want to make driving and next-gen highly connected vehicles safe for my friends, family, peers, and children.

5. What would someone be surprised to know about you?  

I never fired anything out of a submarine.


Join Dionis from Guardknox on 13th September 2021, 3PM London/10AM New York for their webinar titled: SOA and the Software Defined Car – From Concept to Reality 

Register your interest today.



Regtech: the essential solution for frictionless AML compliance

It’s undeniable that financial criminals and their tactics are becoming more sophisticated every day. With incidents of fraud rising dramatically, banks and financial institutions (FIs) are often on the frontline to combat these evolving risks and threats. In a united effort to prevent financial crimes, global and local regulators create far-reaching Anti-Money Laundering (AML) policies, laws and regulations.

To comply with AML regulations, FIs are legally required to continually update their internal policies and build out more comprehensive compliance programs. However, as security controls continue to advance, the time and resources needed to keep up with evolving regulatory requirements are proving to be major challenges for the financial services industry. When time is of the essence, regulatory technology (regtech) has become an essential tool for FIs to stop bad actors through improved Know Your Customer (KYC) and Customer Due Diligence (CDD) processes.

Banks are key players in money laundering prevention
Handling large amounts of illegal cash is a major liability for financial criminals. To avoid suspicion, criminals turn to money laundering as FIs will only deposit money that appears to come from legitimate sources. As one of the most common forms of organized crime, there are multiple ways to launder money and the techniques range from simple to extremely complex. No matter the technique, money laundering is typically a three-step process involving placement, layering and integration:

  • The money laundering process begins when illegal funds (also known as dirty money) are placed into a legitimate financial system
  • Through a series of layered transactions and wire transfers to multiple accounts, the real source of the dirty money can be concealed to eventually produce what looks like legitimate funds
  • Once the dirty money is clean and integrated into the financial system, criminals can withdraw the laundered funds from legitimate accounts to finance their nefarious activities

To stop financial criminals in their tracks, AML policies enact various controls to monitor suspicious activity that could indicate money laundering, such as unusually large cash deposits on an account, or reluctance to provide normal information when opening an account. These policies help banks and FIs detect and prevent money launderers from masking illegal funds as legitimate income.

Through these regulations, banks are required to collect customer information, monitor and screen their transactions and report suspicious activity to financial regulatory authorities. Banks are also required to hold deposits in an account for at least five business days. This holding period helps mitigate risks associated with money movements.

The fundamentals of AML for banks
As the gatekeepers of the financial system, banks and FIs are held to high standards to identify and prevent money laundering. While each jurisdiction will have specific requirements, the four fundamentals of an AML compliance program for banks include:

  • KYC
  • CDD
  • Ongoing monitoring
  • Suspicious activity reporting

As the first step in an AML compliance program, KYC is the process of identifying and verifying a customer’s identity. In other words, banks need to determine that their customers are who they say they are.

While a KYC check is initially conducted when customers open an account, banks are also required to update their customers’ KYC details over time. Should a customer fail to meet minimum KYC requirements, banks can refuse to open an account or cease working with them. A KYC check can be done using:

To further verify customer identities and the nature of their businesses, the CDD process allows banks and other FIs to collect information and assess the risk a customer may pose for money laundering or terrorist financing. The information collected as part of this process will be analyzed against a variety of sources, including both public and private databases, politically exposed persons (PEPs), government records, watchlists and sanctions screening.

Ongoing monitoring
While KYC and CDD processes are needed to establish the baseline of risk and intent, ongoing monitoring is vital to detect any potential suspicious behavior that may reveal itself over an extended period of time. To monitor a customer’s risk profile or business relationship, banks and FIs will need to:

  • Continuously monitor transactions to ensure a customer’s risk profile matches their behavior
  • Watch out for any changes in risk profile, or any factors that could be deemed suspicious
  • Maintain relevant records, documents, data and information that may be needed for CDD purposes

Suspicious activity reporting
To further prevent criminal behavior, if a suspicious transaction is detected by a FI, they are required to report it to financial authorities. A Suspicious Activity Report may be triggered if there’s any transaction behavior that seems out of the ordinary, that might be a precursor to a crime, or that might threaten the safety of the public. Suspicious Activity Reports are vital for law enforcement efforts and the development of future legislation through the analysis of emerging trends in financial crime.

Offloading the burden of AML compliance with regtech
While banks and FIs are legally obligated to comply with AML regulations, they can be met with some reluctance. With implementation often being costly and ineffective, it begs the question: what’s the true benefit of these policies? Meanwhile, compliance teams are nearly at capacity for bandwidth with 80% of their workday occupied with issues of low materiality or risk.

To circumvent this strain on vital resources, regtech software has become the essential solution to help organizations streamline their workflow for list screening, processing results, record keeping, and regulatory reporting. Backed by the advantage of efficiency and automation, modern regtech solutions can help ease pressures, saving organizations time, money and the hassles and financial impacts of avoidable regulatory inquiries and/or fines. This is a major feat for compliance teams with the added ability to focus on the highest-priority compliance issues.

As risks and threats continue to evolve, responsive and forward-thinking solutions will provide banks and FIs the greatest opportunities to meet AML compliance and global regulations while protecting their bottom lines. Empowered by rapid, low-cost and frictionless accuracy, regtech can facilitate the balancing act that’s needed to ensure thorough and comprehensive AML and KYC checks without disrupting customers and processes.

With AML regulations growing in complexity globally, it’s important that banks and FIs seek to develop compliance programs that are effective, efficient and sustainable. Learn how to best prepare for the new era of AML enforcement in Europe. Register for the Everything you need to know about 6AMLD  webinar today.


Spotlight Interview with Rhoanne McPherson, Principal Scientist at Concept Life Sciences

What do you hope attendees will gain at your webinar? 

I hope that attendees will gain a useful and interesting overview of immunotherapy drug discovery, including key targets, platforms and tools to test drug efficacy, as well as discussion of the challenges and emerging areas within the field.


What discussions do you look forward to having with the attendees?

 We love to talk to people who are on all stages of their drug discovery journey, and are always interested to hear about the different targets and approaches that people are using or interested in. We’re more than happy to discuss any challenges and issues that potential clients might be having and ultimately investigate how we can help!


What do you enjoy most about your role? 

The best thing about my role is that it’s diverse and innovative, and there is no standard or dull day. We’re constantly developing new assays and approaches to better model diseases and provide our clients with the best, most relevant platforms to assist with their drug development.  We really do learn something new every day, and we love passing on that new-found knowledge and expertise to our customers, to see how it can benefit them.


How did you get into the industry? 

Part of our company was originally formed as a spin-out from the University of Edinburgh and I happened to be a Post-Doctoral Researcher in the academic group that started that company! I was driven to make the jump into industry as I was keen to take on new and diverse challenges and be at the forefront of immunology drug discovery – I knew that we could make a positive impact, and that decision has been proven to be right every day since!


Where is your favourite place in the world and why?

 I’d be tempted to say somewhere tropical or exotic, but it’s honestly probably where I live. I’m lucky enough to call a coastal village in Scotland with a beautiful beach, surrounded by lovely countryside, my home. Having to endure two national lockdowns due to COVID-19 has given me a newfound appreciation for the nature and stunning views that are right on my doorstep!

Register now –

Spotlight Interview with Chris Baron, Director of Business Development, Pulmonary Category, Aptar Pharma

Why did you decide to do a webinar with us?

Every organisation working in pulmonary drug delivery is facing the same challenge: how to move away from propellants such as hydrofluoroalkanes HFA P227 and HFA 134a towards newer, more environmentally friendly approaches aimed at further reducing the sector’s carbon footprint. This challenge must be overcome without losing sight of two fundamental priorities: ensuring patient safety and supporting regimen adherence.

Both Jag Sur (my co-presenter and CEO of Nanopharm) felt it important to review the key challenges involved in developing low carbon pMDIs and then explain how Aptar Pharma can support its partners programs by derisking and accelerating the development, scale-up and commercialization of inhalers with lower carbon footprints.

What will the audience gain from attending your webinar?

We will address the technical, regulatory, manufacturing and R&D considerations in delivering more sustainable alternatives.

How did you get into the industry and what do you most enjoy about your role?

I have been working in the field of inhalation drug delivery for over 30 years, gaining significant expertise in metering valve technologies for pressurised metered dose inhalers and their accessory/ peripheral device technologies, including dose indicators and breath-activated inhalers.

It gives me great satisfaction to know that the solutions we create make a tangible difference to the quality of life of millions of people around the world, every day.

What are you hoping to achieve in the future in your personal and professional life?

From a professional perspective, I would like to play an integral role in the redefining of the asthma inhaler landscape and see through the implementation of new, more sustainable propellant(s).

From a personal perspective, stay healthy, continue to run, cycle and compete in another Tough Viking event. Most importantly, continue to beat my two sons in our Lock-Down Olympics

Register now

AM Session –

PM Session –

Spotlight Interview with Richard Price, Sales Director FSI UKI at TIBCO






Richard Price, Sales Director FSI UKI

What do you hope attendees will gain at your webinar?

Hopefully it will be an interesting and interactive session to help attendees appreciate noy just the challenges of Cloud disruption but the opportunity it presents – and the best way they can exploit those opportunities depending on their specific context.  I would also suggest it will give a good barometer for those attending of where they are comparatively in the data strategy maturity 

What discussions do you look forward to having with the attendees? 

For me it is an opportunity to validate the reality of a “wave” of disruption that is “accepted” within the vertical, and get an assessment of where different organisations are in that journey.  It would be interesting to see if challenges and opportunities are consistent, and if the maturity of those attending in terms of Cloud transformation and data management strategies is consistent 

What do you enjoy most about your role?

Working with customers and partners to genuinely transform their organisations operations, through innovation and collaboration.  It’s always an exciting moment when you work as a team to realise the conception of a deliverable project that will have a genuine impact on those involved as well as the wider business   

How did you get into the industry? 

By accident!  I was initially taking a direction in financial services when I got involved in a graduate placement scheme in the software industry – which really appealed to a sense of teamwork with academic curiosity and problem solving that was immediately accessible even at a relatively junior level.

Where is your favourite place in the world and why? 

Alnmouth, Northumberland.  The view in the evening across the beach and estuary is just stunning.  I have a lot of happy memories of it from my childhood and now with my children too. 

Spotlight Interview with Reza Mehman, Chief Innovation Officer at Onapsis





Reza Mehman

What do you hope attendees will gain at your webinar?

A good understanding of criticality and risks, especially in the financial services industry. Cyber crime and its financial consequences are one of the greatest risks for the financial sector. Not only the regulatory penalties are to be considered, but also the loss of customer confidence.


What discussions do you look forward to having with the attendees?

Discussions around which technological trends can help organisations to be better prepared for cyber attacks in an highly interconnected and digitized environment.


What do you enjoy most about your role?

Being part of the Innovation Team is great! We tackle really interesting new trends and technologies to help our customers secure their applications.There is always something new to learn.


How did you get into the industry?

Former business partners of mine were leading a cyber security company. I really got interested in topics around security & compliance. So I asked my business partners how I can engage myself in this great industry.


Where is your favourite place in the world and why?

To be honest. I love Heidelberg, Germany. I have lived here almost all my life but I’m still impressed by its beauty and the open-minded culture. The Heidelberg Castle, the Neckar river, the Old Town. A lot of beautiful places to visit. I guess that Mark Twain was right: The city was “the last possibility of the beautiful”.


Join Reza Mehman live for the Webinar, Hackers Are Targeting the Financial Industry, this September 20th 2021 on 2pm London.

Preguntas destacadas de la entrevista a Matthias Birkhoff, vicepresidente de Desarrollo de Negocios de Aptar Pharma

1/  ¿Por qué decidió hacer un webinar con nosotros?

Las enfermedades oftálmicas son un desafío global y los referentes del sector están esparcidos por todo el mundo. Este webinar nos permite interactuar en forma directa con nuestros colegas, cumpliendo con nuestra promesa de sustentabiliad, y sin tener que viajar.


2/  ¿Cuáles serán los beneficios para el público que asista al webinar?

Aptar Pharma es un líder mundial en la administración de fármacos por vía pulmonar y nasal. Al utilizar nuestra experiencia y conocimientos de prestigio internacional, ahora estamos replicando nuestra posición de liderazgo en el mercado en el cuidado de los ojos. Con más de 250 referencias en el mercado, queremos destacar cómo nuestra creciente cartera de soluciones para el cuidado de los ojos es la plataforma de referencia para la administración de fármacos oftálmicos.


3/ ¿Cómo ingresó en el sector y qué es lo que más le gusta de su rol?

Me formé en el campo de la medicina. Los dispositivos eran realmente una incógnita cuando ingresé en Aptar Pharma, hace más de 20 años. Hoy, muchos de nosotros reconocemos que la tecnología de dispensado es tan fascinante no solo como los fármacos sino también como las enfermedades contra las que se lucha.


4/ ¿Qué espera lograr en el futuro, tanto en el plano personal como en el profesional?

Desde un punto de vista profesional, me encantaría ver el día en que las enfermedades de la retina sean tratadas con fármacos que se administren por vía tópica. De esta manera, las excelentes oportunidades que existen hoy para los tratamientos para la retina podrían llegar a más pacientes en todo el mundo.

En lo personal, necesito mejorar mis habilidades como trompetista…


5/ ¿Qué nos sorprendería saber de usted?

Dirijo una big band, aunque ahora no podemos ensayar como lo hacíamos antes.

Regístrate ahora –


Spotlight Interview with Ayse Sabuncu, Principal Consultant, European Energy Markets






What will the audience gain from attending your webinar?

In the next two decades, the decarbonisation of the transport and heating sectors is expected to happen mainly through electrification. This will in turn increase the electricity demand and will require sufficient generation resources to be available to meet the increasing demand.

In our webinar, we will provide our audience an overview of the transport and heat sectors’ policy targets, discuss how the electrification of these sectors might impact the power sector’s electricity consumption (both in terms of volume and shape), explore the interrelationship between the changing demand shape, increasing variable generation coming from renewable energy sources and flexibility technologies such as battery storage and demand side response and finally showcase the impact of this transformation on the electricity price.


How did you get into the industry and what do you most enjoy about your role?

I was an economics graduate with a couple of years of business and research experience when I saw a newspaper ad regarding the job. I did not know anything about the power industry or knew anyone working in it, but from the moment I started talking to my future manager, I was fascinated by it and knew I wanted to learn and understand more.

I have always loved working in the energy sector which has not disappointed me in terms of providing new challenges since 2001. When I started working in the sector, my first job was building the electricity market database for Europe, and maybe except for Spain, there was no wind or solar resources installed. And now look at it, Europe met around 38% of the total consumption from renewables in 2020! And this is expected to rise to 60% in 2030.

I am also very concerned about the sustainability of the resources and very glad that I can contribute to the ultimate goal by providing analysis/tools that clients can use to reduce their carbon footprint and increase their investment in renewables, battery and other types of zero-emission technologies or/and technologies abating the emissions.


What are you hoping to achieve in the future in your professional life?

I want to continue to play my part to the best of my abilities doing my job supporting the clients in their decarbonisation efforts, be a great coach and inspiration for new joiners and other team members, and while doing all that maintain a balanced work/family life.


Why did you decide to do a webinar with us?

We have been working with Business Review over the past few years to bring our award-winning solutions to the energy sector.


What would someone be surprised to know about you?

I am passionate about flamenco music and dance and have been an amateur dancer since 2012. I love nature and my house is full of specimen of shells, dried leaves, and feathers I have been collecting. They help me feel connected with nature.


Join Ayse Sabuncu live on the webinar Understanding the impact of energy demand decarbonisation on electricity markets this July 7th 2021 at 2pm London.

Spotlight Interview with Bob Tiling, Life Sciences Labelling Specialist at Kallik Ltd






What do you hope attendees will gain at your webinar?

I hope the attendees will gain an insight as to how the latest generation of artwork and labelling software can handle repetitive tasks, thus leaving the users more time to think about the creative side of artwork and labelling. They will have a better understanding of how large volumes of artworks or labels can be changed very quickly and accurately by using previously approved content and automation technology.

What discussions do you look forward to having with the attendees?

I am looking forward to discussing how content should be re-used to reduce errors and improve artwork or label consistency plus discussions around getting the right information on the right label or artwork with the assistance of rules engines and automation technology.


What do you enjoy most about your role?

My background is in sales so I enjoy gaining the confidence of new customers and ultimately winning their work. I get to see artwork and labelling projects delivered. I get to keep in touch with a group of very satisfied customers. I enjoy it when they come back to me for an expansion of the original solution following on from its initial success.


How did you get into the industry?

By accident! My local labelling software company were looking for a sales person to start immediately due to several people leaving at short notice. I was available immediately so I satisfied that requirement. I secured a 3 month trail which led to a 6 month trial. I went on to serve them for 10 years and became very passionate about labelling.


Where is your favourite place in the world and why?

Where is your favourite place in the world and why? I like to be walking in the mountains, no particular country or location, just in the mountains. I enjoy the views, the peacefulness, the clean air and of course the challenge itself of walking in the mountains.


Join Bob Tiling live on the webinar: 6 steps to overcome labelling challenges in the life sciences industry: How to drive efficiency & control through digital maturity this September 15th 2021, 4PM London